To support the pulmonary hypertension (PH) health care community, clinicians, allied health care providers and researchers, the Pulmonary Hypertension Association (PHA) has compiled the following resources. These resources include the latest information on the science, clinical trials and patient care management in response to the COVID-19 pandemic.
Clinical studies related to COVID-19 in ClinicalTrials.gov
World Health Organization’s R&D Blueprint to accelerate diagnostics, vaccines and therapeutics in response to COVID-19
Latest COVID-19 information from the Food and Drug Administration
Milken Institute’s Vaccine Tracker for a summary of COVID-19 vaccine programs
COVID-19 updates from the Bill & Melinda Gates Foundation
PHA’s COVID-19 Frequently Asked Questions (FAQ) for the PH community
CDC information for health care professionals including Evaluation and Testing and Clinical Care Guidance for COVID-19
CDC Facts Sheet for health care professionals on diagnostic testing
CDC resources for dealing with stress and anxiety during the COVID-19 pandemic
PubMed articles referencing patient care management for PAH patients with COVID-19
- “Could pulmonary arterial hypertension (PAH) patients be at a lower risk from severe COVID-19?” Rosenzweig et al. Pulmonary Circulation, April 2020.
- “Care of patients with Pulmonary Arterial Hypertension during the Coronavirus (COVID-19) pandemic.” Ryan et al. Pulmonary Circulation, March 30, 2020.
COVID-19 Interim Guidance on Management Pending Empirical Evidence guidance document from an American Thoracic Society-led international task force
American College of Cardiology Palliative Care Considerations for Patients with Cardiovascular Disease Under COVID-19
NIH COVID-19 resources
Guidance for NIH grant applicants and recipients in response to COVID-19
NIAID special COVID-19-related grant funding opportunities
NIAID resources for researchers including reagents, core services, and model systems to support COVID-19 research
NIH guidance on limiting travel and meetings